Financial statements Deep Pharma

Balance sheet of Deep Pharma

Company age:
Age:
8 y. 7 m. 15 d.
Share capital:
Share capital:
5 000 PLN

Balance sheet data of DEEP PHARMA

Year
2018
2019
2020
2021
2022
2023
2024
Total assets 1 659 415,79 2 110 475,16 1 712 001,95 1 797 171,73 2 382 678,59 2 719 647,84 2 468 749,97
A. Fixed assets 29 311,05 23 681,85 18 573,01 15 661,01 12 788,85 9 916,69 7 044,53
B. Current assets 1 630 104,74 2 086 793,31 1 693 428,94 1 781 510,72 2 369 889,74 2 709 731,15 2 461 705,44
C. Share capital contributions (basic funds) 0,00 0,00 0,00 0,00 0,00 0,00 0,00
D. Own shares (stocks) 0,00 0,00 0,00 0,00 0,00 0,00 0,00
Total liabilities 1 659 415,79 2 110 475,16 1 712 001,95 1 797 171,73 2 382 678,59 2 719 647,84 2 468 749,97
A. Equity -3 499 517,20 -4 735 475,39 -5 268 048,26 -5 180 857,35 -4 096 847,30 -2 940 968,63 -1 368 796,99
B. Liabilities and provisions for liabilities 5 158 932,99 6 845 950,55 6 980 050,21 6 978 029,08 6 479 525,89 5 660 616,47 3 837 546,96
I. Long-term liabilities 2 662 025,04 4 546 613,03 6 742 362,22 6 693 376,80 5 366 696,55 4 570 688,40 2 448 000,00
II. Short-term liabilities 2 496 907,95 2 299 337,52 237 687,99 284 652,28 1 112 829,34 1 089 507,25 1 389 305,46
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.

  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.